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Abstract
Farnesoid X receptor (FXR) is a nuclear receptor that regulates bile acid metabolism and transport. Mice lacking expression
of FXR (FXR KO) have a high incidence of foci of cellular alterations (FCA) and liver tumors. Here, we report that Helicobacter
hepaticus infection is necessary for the development of increased hepatitis scores and FCA in previously Helicobacter-free
FXR KO mice. FXR KO and wild-type (WT) mice were sham-treated or orally inoculated with H. hepaticus. At 12 months post-
infection, mice were euthanized and liver pathology, gene expression, and the cecal microbiome were analyzed. H.
hepaticus induced significant increases hepatitis scores and FCA numbers in FXR KO mice (P,0.01 and P,0.05, respectively).
H. hepaticus altered the beta diversity of cecal microbiome in both WT and FXR KO mice compared to uninfected mice (P,
0.05). Significant upregulation of b-catenin, Rela, Slc10a1, Tlr2, Nos2, Vdr, and Cyp3a11 was observed in all FXR KO mice
compared to controls (P,0.05). Importantly, H. hepaticus and FXR deficiency were necessary to significantly upregulate
Cyp2b10 (P,0.01). FXR deficiency was also a potent modulator of the cecal microbiota, as observed by a strong decrease in
alpha diversity. A significant decrease in Firmicutes, particularly members of the order Clostridiales, was observed in FXR KO
mice (P,0.05 and FDR,5%, ANOVA). While FXR deficiency strongly affects expression of genes related to immunity and bile
acid metabolism, as well as the composition of the microbiome; however, its deficiency was not able to produce significant
histopathological changes in the absence of H. hepaticus infection.
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Introduction
Natural enterohepatic Helicobacter spp. infection is 88%
prevalent in research mouse colonies worldwide [1]. While most
infected mice develop minimal pathologic changes, susceptible
strains exhibit typhlocolitis and hepatitis, which can progress to
colon cancer and hepatocellular carcinoma [2]. H. hepaticus-
associated hepatitis and hepatocellular carcinoma were originally
identified in control A/JCr mice being used in a toxicology study
at the National Cancer Institute [3,4]. A subsequent retrospective
study identified 9 National Toxicology Program two-year carci-
nogenicity studies where male B6C3F1 mice exhibited increased
hepatitis and liver neoplasia associated with H. hepaticus infection,
thus confounding study interpretations [5]. A high prevalence of
enterohepatic Helicobacter spp. infection in a research mouse
colony has prompted extensive eradication efforts via medicated
diets, testing and quarantine strategies, and embryo transfer
rederivation [2,6,7].
Other related enterohepatic species isolated in mice, such as H.
bilis and H. pullorum, have been identified in patients with
cholecystitis and biliary neoplasia [8,9]. Mouse H. hepaticus
infection has also been utilized as a microbe-induced hepatitis and
liver cancer model [10–13]. In constitutive androstane receptor
(CAR) knock-out (KO) mice, H. hepaticus infection similarly
promoted hepatic inflammation, dysplasia, and neoplasia [13]. In
this model, pathology correlated with elevated serum bile acid
levels and phase I hydroxylation enzyme gene dysregulation.
These findings illustrate the importance of CAR-mediated
metabolic regulation in preventing infection-associated inflamma-
tion and neoplastic progression [13].
In a manner similar to CAR, the farnesoid X receptor (FXR)
plays a central role in regulating bile acid synthesis and transport,
as well as glucose and lipid homeostasis [14,15]. In FXR KOmice,
the loss of FXR regulatory function causes increases in serum bile
acids and accumulation of hepatic bile acid, leading to steatosis
and hepatocellular injury. Prior studies hypothesized that these
metabolic derangements caused oxidative stress and hepatocellular
proliferation, which then triggered hepatic foci of cellular
alteration (FCA), hepatocellular adenomas and carcinomas, and
mixed hepatocellular-cholangiocellular carcinomas [16,17]. FXR
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KO mice were thus presented as a model to study hepatobiliary
pathophysiology and neoplasia. However, these reports did not
describe the microbial pathogen status of the mice used in these
studies.
Because Helicobacter spp. cause hepatitis and liver cancer in
susceptible mouse strains and are widespread in research mouse
colonies [1], we sought to determine whether enterohepatic
Helicobacter infection promoted neoplastic progression in this
important liver cancer model. Prior to the study, FXR KO and
WT mice were embryo transfer rederived to produceHelicobacter-
free mice, which were confirmed as Helicobacter-negative by fecal
PCR prior to infection. In this study, Helicobacter-free 2-month-
old FXR KO mice were inoculated with either H. hepaticus or
sterile media by oral gavage. After 1 year, liver pathology and gene
expression were evaluated. Increased expression of pro-inflamma-
tory and bile acid metabolism genes was observed in all FXR KO
mice, but only H. hepaticus-infected FXR KO mice had
significantly greater altered cell foci numbers and hepatitis scores
compared to infected WT mice and sham-treated controls. As
hepatic pathology was associated with intestinal H. hepaticus
infection, we evaluated the effects of FXR deficiency and H.
hepaticus infection on the cecal microbiome via 16S rRNA
sequencing. While FXR was the primary factor behind changes in
the cecal microbiota, H. hepaticus infection alone was able to
reshape the microbial community.
Results
FXR KO mice have enlarged livers and increased serum
bile acids
Cecal and hepatic H. hepaticus colonization levels were
quantified using qPCR. Ceca from infected mice, regardless of
their genotype, were H. hepaticus-positive and were colonized at
similar levels, averaging 104–105 bacteria per mg total cecal DNA,
while sham-treated animals remained negative (Fig. 1A). Livers
from all mice were H. hepaticus-negative. Both H. hepaticus-
infected (mean liver weight/body weight ratio = 5.56%) and
sham-treated (6.20%) FXR KO mice had significant hepatomeg-
aly compared to WT mice (sham-treated - 4.46%, and H.
hepaticus-infected - 4.35%, P,0.05, Fig. 1B). A reduction in body
weight among FXR KO mice (sham-treated = 44.89610.43, H.
hepaticus-infected = 42.9469.87) compared to WT mice (sham-
treated = 50.3167.78, H. hepaticus-infected = 48.8868.63)
contributed to this change. H. hepaticus-infected (median
= 33.49 mM) and sham-treated (35.22 mM) FXR KO mice also
had significantly elevated serum bile acids compared to uninfected
WT mice (17.33 mM, P,0.05 in both groups, Fig. 1C). Significant
differences in liver weight – body weight ratio and serum bile acids
were not noted between sham-treated WT and H. hepaticus-
infected WT mice or between sham treated FXR KO and H.
hepaticus-infected FXR KO mice.
H. hepaticus infection is necessary to promote liver
damage and preneoplastic lesions in FXR KO mice
Following histopathologic evaluation of livers, mean hepatitis
index (HI) was significantly elevated in infected FXR KO mice
(1.6362.25, mean 6 SD) when compared to sham-treated WT
mice (0.08360.192, P,0.01), characterized by prominent portal
inflammatory aggregates (chiefly B and T cells) and mild lobular
inflammation (lymphocytes and macrophages) (Fig. 2A). Infected
WT (0.36160.479) and sham-treated FXR KO mice
(0.47160.856) had slight increases in mean hepatitis scores
compared to uninfected WT mice. It should be noted that there
was moderate variation in the grade of hepatic inflammation
between animals even within infected FXR KO mice as shown in
figures (Fig. 2C & D). On immunohistochemistry, the portal and
distinct lobular inflammatory foci of infected FXR KO mice livers
were comprised of a large population of CD45B220+ B cells with a
significant intermingling of CD3+ T cells with sparse to no F4/80+
macrophages and MPO+ neutrophils (Fig. S1). The same
inflammatory cellular profile was also observed in WT infected
mice albeit in a lower intensity reflecting the lower HI scores of
this group (data not shown). Significantly increased mean FCA
was also noted only in H. hepaticus-infected FXR KO mice
(0.81361.38) when compared to WT mice (0 and 0.05660.243,
P,0.05, Fig. 2E). For example, eosinophilic FCA (Fig. 2F)
comprised circular foci of hepatocytes distinguishable from
adjacent normal hepatic parenchyma predominantly by enlarged
hepatocytes with hypereosinophilic staining intensity, with some
cytoplasmic granularity; and clear cell FCA (Fig. 2G) were
characterized by circular foci of normal-sized to enlarged
hepatocytes with distinct cytoplasmic clear spaces. In all cases,
FCA were associated with minimal to no compression of
surrounding liver tissue. Sham-treated FXR KO mice had an
intermediate mean hepatic FCA number (0.23560.437).
Absence of FXR promotes expression of
pro-inflammatory and bile acid metabolism genes
H. hepaticus infection and FXR KO genotype-associated
neoplastic progression have both been associated with differential
inflammatory and metabolic gene expression [12,13,16–18]. Thus,
hepatic gene expression was evaluated using qPCR (Fig. 3). Both
infected and sham-treated FXR KO mice had significantly greater
expression of pro-inflammatory genes encoding b-catenin (P,
0.01), inducible nitric oxide synthase (P,0.001), NF-kB subunit
p65 (Rela) (P,0.001), and toll-like receptor 2 (P,0.001) relative
to sham-treated WT mice. While significant, these changes were of
small magnitude- less than 2-fold change- in b-catenin and Rela.
Compared to WT sham mice, only sham-treated FXR KO mice
expressed significant increases in interleukin-1b (P,0.05) expres-
sion. Tumor necrosis factor alpha (TNFa) and transformation-
related protein 53 (Trp53) was not significantly different between
any FXR KO group and WT sham mice. However, when
evaluated relative to H. hepaticus-infected WT mice, all 7
inflammation-related genes had significant increases in both H.
hepaticus-infected and uninfected FXR KO mice (b-catenin (FXR
KO Hh, P,0.001; FXR KO sham, P,0.01); interleukin-1b
(FXR KO Hh, P,0.05; FXR KO sham, P,0.01); inducible nitric
oxide synthase (both P,0.001); NF-kB subunit p65 (Rela) (both
P,0.001); toll-like receptor 2 (both P,0.001); TNFa (FXR KO
Hh, P,0.05; FXR KO sham, P,0.01); and transformation-
related protein 53 (Trp53) (FXR KO Hh, P,0.05; FXR KO
sham, P,0.001)). While no significant differences were observed
due to H. hepaticus infection alone comparing uninfected vs.
infected WT mice or uninfected vs. infected FXR KO mice, H.
hepaticus infection slightly decreases expression of inflammatory
genes such as IL-1b, Nos2, Tlr2, TNFa and Trp53.
Genes involved in bile acid recognition and hydroxylation were
also differentially expressed in sham-treated and infected FXR
KO mice (Fig. 3). Vitamin D receptor (VDR) gene expression was
significantly higher in H. hepaticus-infected and sham-treated
FXR KO mice compared to uninfected WT (both P,0.001).
VDR is a nuclear receptor that binds both vitamin D and
secondary bile acids, particularly lithocolic acid. Expression of
Slc10a1, which encodes the Solute Carrier Family 10 Member 1
(NTCP), was reduced in both H. hepaticus-infected and sham-
treated FXR KO mice compared to sham-treated WT (FXR KO
Hh, P,0.05; FXR KO sham, P,0.01). Activation of FXRa by
Helicobacter hepaticus in FXR KO Mice
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binding bile acids represses hepatic bile acid transporter NTCP,
encoded by Slc10a1 [19]. Expression of bile acid hydroxylation
enzyme cytochrome P450 3A11 was significantly greater in H.
hepaticus-infected (P,0.001) and sham-treated FXR KO mice
(P,0.01) relative to sham-treated WT mice. However, cyto-
chrome P450 2B10 gene expression was only significantly greater
in H. hepaticus-infected FXR KO mice relative to uninfected WT
mice (P,0.01), suggesting that H. hepaticus might induce 2B10
expression in FXR KO mice. Importantly, when infected FXR
KO mice were sorted based on FCA presence, a significant 2.73-
fold increase in 2B10 gene expression was observed in H.
hepaticus-infected FXR KO mice with FCA compared to similarly
treated mice without FCA (P,0.01). Similar to the inflammatory
genes, comparison of both H. hepaticus-infected and uninfected
FXR KO groups toH. hepaticus-infected WT mice had significant
changes in all 4 genes (Cyp2b10 (FXR KO Hh, P,0.001; FXR
KO sham, P,0.01); Cyp3a11 (FXR KO Hh, P,0.001; FXR KO
sham, P,0.01); Slc10a1 (FXR KO Hh, P,0.05; FXR KO sham,
P,0.001); and Vdr (FXR KO Hh, P,0.001; FXR KO sham, P,
0.01)). No significant changes were observed within mice of the
same genetic background by H. hepaticus infection alone, but
interestingly slight increases in Cyp2b10, Cyp3a11 and Vdr
expression were observed in H. hepaticus-infected FXR KO mice.
Genes encoding interleukin 6, constitutive androstane receptor
(CAR), pregnane X receptor (PXR), cathelicidin (CAMP), and
ATP-Binding Cassette, Sub-Family C Member 2 (Abcc2, encoding
MRP2) were not differentially expressed in any of our study
groups. Gene expression data demonstrated that H. hepaticus
infection did not alter the expression of two liver genes, Slc10a1 or
Abcc2, directly regulated by FXRa and involved in bile acid
transport and secretion. This suggested that H. hepaticus may
mediate increased liver damage through pathways not directly
controlled by FXR.
FXR and H. hepaticus Independently Alter Microbial
Diversity and Composition
Next we tested the effects of FXR on the microbiota in the
presence of concurrent H. hepaticus infection by sequencing 16S
rRNA amplicons obtained from cecal DNA derived from sham-
treated and H. hepaticus-infected WT and FXR KO mice. Data
analysis and normalization were performed by using QIIME 1.7.0
as described in the Methods section. The 16S rRNA-based
microbiota community analysis revealed significant differences in
alpha and beta diversity between FXR KO and WT mice. Using
both the Shannon index and Chao1 richness estimate, a significant
decrease in alpha diversity was observed in the fecal microbiota of
sham FXR KO compared to either sham WT mice or H.
hepaticus-infected FXR KO mice (Fig. 4A and 4B, P,0.05 in
both Shannon and Chao1, two-sample t test). These results suggest
a decreased evenness (relative abundance of species) and richness
(total number of species) caused by the absence of FXR that was
compensated by H. hepaticus infection.
Principal coordinate analysis (PCoA) of unweighted UniFrac
distances revealed clustering of microbial communities based on
the FXR status of mice (Fig. 4C and Table 1, P=0.001,
permutational multivariate analysis of variance (PERMANOVA))
and H. hepaticus status (P=0.001, PERMANOVA). Taking into
account the relative abundance of organisms, PCoA of weighted
UniFrac distances recapitulated clustering based on FXR status
(Fig. 4D, P=0.005, PERMANOVA) but not H. hepaticus
infection (P=0.515, PERMANOVA). As FXR function was the
primary variable causing changes in the composition of the
microbiota, we assessed the individual effects of H. hepaticus and
FXR status in subgroups of interest (Table 1 and Figs. S2 and S3).
Controlling for FXR status, H. hepaticus induced significant
differences in WT and FXR KO groups using unweighted
UniFrac distances, but not weighted UniFrac analysis (Table 1).
Accounting for infection status, the loss of FXR function induced
significant changes in both sham and H. hepaticus-infected mice
using unweighted UniFrac distances. In the analysis of the
weighted UniFrac distances, the FXR status did not affect the
microbiome in uninfected mice, but had an effect in H. hepaticus-
infected mice (Table 1).
FXR and H. hepaticus Significantly Affect the Relative
Abundance of Bacterial Taxa
Follow-up analysis disclosed significant differences in the
relative abundance of bacterial taxa between FXR KO and WT
mice at multiple taxonomic levels (Table 2 and Fig. 5 as judged by
ANOVA with false discovery rate (FDR) ,5%). Members of the
phylum Firmicutes significantly decreased in FXR KO mice
(46.3% of total bacteria) compared to WT mice (61.5%, Table S1).
While a compensatory increase in the phylum Bacteroidetes was
observed in FXR KO mice, it did not surpass the FDR threshold
set (36.19% in FXR KO mice vs. 25.97% in WT mice, P=0.026,
FDR =12%).
To investigate this further, we ranked the top 25 genera in each
group, which represented more than 99% of total reads, by
Figure 1. Absence of FXR promotes hepatomegaly and increased serum bile acids. A) Experimental group mean cecal Helicobacter
hepaticus colonization levels 6 SD determined by probe-based qPCR and expressed relative to cecal DNA quantity. B) Mean mouse liver weight –
body weight ratio 6 SD and C) median serum bile acid levels 6 IQR are shown for each experimental group. *P,0.05, **P,0.01, and ***P,0.001 vs.
WT sham-treated mice.
doi:10.1371/journal.pone.0106764.g001
Helicobacter hepaticus in FXR KO Mice
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relative abundance (Table S2). Comparing the effect of FXR
status, we observed Anaerostipes, Desulfovibrio, and unknown
genera in the orders Clostridiales and Bacteroidales in the top 25
genera in sham treated WT mice. However, in sham treated FXR
KO mice, these genera were replaced in the top 25 by rc4-4,
Prevotella, Turicibacter, and an unknown genus in family
Lactobacillaceae. Similarly, H. hepaticus-infected WT had higher
abundance of Desulfovibrio, Bilophila, Stentrophomonas, and
unknown genera in the order Bacteroidales and the family
Clostridiaceae, while in H. hepaticus-infected FXR KO mice,
these genera were replaced by rc4-4, Prevotella, Akkermansia,
Turicibacter, and Coprococcus. Using ANOVA, we analyzed the
effect of FXR at the genus level (Table 2). As observed above, an
unclassified genus in the order Bacteroidales represented one of
the most prominent findings as its abundance decreased in FXR
KO mice compared to WT mice (P,0.05 and FDR ,5%,
ANOVA). Conversely, the family Prevotellaceae within the
phylum Bacteroidetes increased significantly in the FXR KO
Figure 2. H. hepaticus infection is necessary for increased liver pathology and preneoplastic lesions in FXR KO mice. A) Mean hepatitis
index (HI) 6 SD is shown for each experimental group (**P,0.01). Representative liver sections from B) sham-treated WT (HI = 0) and H. hepaticus-
infected FXR KO mice showing C) typical (HI = 1.5) and D) severe (HI = 6.5) hepatitis. H&E-stain, bar = 100 mm. E) Mean FCA count 6 SD is shown for
each experimental group (*P,0.05). Examples of F) eosinophilic and G) clear cell foci from H. hepaticus-infected FXR KO mice (outlined by arrows;
H&E-stain, bar = 600 mm).
doi:10.1371/journal.pone.0106764.g002
Helicobacter hepaticus in FXR KO Mice
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mice (0.26% of total reads) compared to the WT mice (0.038%,
P,0.05 and FDR ,5%, ANOVA). At both the class and the
order level, a significant decrease in bacteria from the class
Clostridia and the order Clostridiales was observed in FXR KO
mice (P,0.05 and FDR ,5%, ANOVA). However, closer
inspection of the microbiome data at the genus level reveals a
more dynamic view with an unclassified genus (family Lachnos-
piraceae) driving the decrease observed at the class and order
levels as a severe decrease in mean relative abundance is observed
in FXR KO (30.72%) mice compared to WT mice (41.48%, P,
0.05 and FDR ,10%, ANOVA). In contrast, increased
abundance in the clostridia from the genera rc4-4 (family
Peptococcaceae) and Oscillospira (family Ruminococcaceae) was
observed in FXR KO mice (Table 2, P,0.05 and FDR ,10%,
ANOVA). The absence of FXR also reduces levels of Desulfovi-
brio, a member of the delta subgroup of Proteobacteria (P,0.05
and FDR ,10%, ANOVA). Collectively, these data show that
FXR regulates the overall diversity and composition of the murine
gut microbiota.
The relative abundance of the Helicobacter OTU was 0.33% in
H. hepaticus-infected FXR KO mice, making it the 55th most
abundant OTU, and 0.12% in H. hepaticus-infected WT mice,
making it the 140th most abundant OTU (Table S3). Comparing
the top 25 genera in WT mice, 3 genera (Akkermansia,
Anaerostipes, and an unknown genus in the family Xanthomona-
daceae) were ranked in the top 25 in sham WT mice but were
replaced by Helicobacter sp., Bilophila sp., and an unknown genus
in the family F16, following H. hepaticus infection. In FXR KO
mice, the top 25 genera in uninfected mice included Stenotropho-
monas and unknown genera in the families Lactobacillaceae,
Clostridiaceae, and Xanthomonadaceae, which were substituted
by Helicobacter sp., Coprococcus sp. and two unknown genera
from the order Clostridiales and the family F16. In both WT and
FXR KO mice, H. hepaticus infection promoted increases in the
genus Helicobacter and the family F16 in phylum TM7, while
negatively affecting the family Xanthomonadaceae. While the
introduction of H. hepaticus into WT mice did not affect alpha
diversity, analysis of sham and H. hepaticus-infected WT mice
revealed shifts in the microbiota present based on PCoA analysis of
Figure 3. Gene expression changes associated with H. hepaticus infection and the absence of FXR. Fold changes of A-G) pro-
inflammatory (b-catenin, IL-1b, Nos2, Rela, Tlr2, TNFa, and Trp53) and H-K) metabolic (Cyp3a11, Slc10a1, Vdr, and Cyp2b10) genes determined by qPCR
are shown for each group relative to WT sham mice. L) Cyp2b10 expression in infected FXR KO mice is shown based on FCA presence vs. absence
(P=0.0028). Box plots represent the average fold change relative to WT sham61 standard deviation. Values represent average fold change relative to
uninfected WT sham. *P,0.05, **P,0.01, ***P,0.001 vs. sham-treated WT mice. #P,0.05, ##P,0.01, ###P,0.001 vs. H. hepaticus infected WT mice.
doi:10.1371/journal.pone.0106764.g003
Helicobacter hepaticus in FXR KO Mice
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Figure 4. FXR KO affects the alpha and beta diversity of the cecal microbiome. A) Sham FXR KO mice showed significant decreases in OTU
richness as measured by Chao1. B) Decreased alpha diversity was also observed using the Shannon diversity index when compared to sham WT and
H. hepaticus infected FXR KO mice. C) Unweighted UniFrac-based PCoA plot of cecal microbial communities from WT and FXR KO mice with and
without H. hepaticus infection reveals clustering based on mouse genotype and H. hepaticus status (P= 0.001 for both, PERMANOVA). D) Weighted
Unifrac-based PCoA plot reveals clustering by mouse genotype (P=0.005, PERMANOVA), but not by H. hepaticus status. *, P,0.05 against both sham
WT and H. hepaticus FXR KO mice.
doi:10.1371/journal.pone.0106764.g004
Table 1. PERMANOVA analysis of Unifrac-based distance matrices.
Unweighted Unifrac P-value Weighted Unifrac P-value
All sham1 vs. All Hh2 0.001 0.515
All WT3 vs. All FXR KO4 0.001 0.005
Subsets
WT sham vs. WT Hh 0.001 0.263
FXR KO sham vs. FXR KO Hh 0.001 0.218
Sham WT vs. Sham FXR KO 0.001 0.053
Hh WT vs. Hh FXR KO 0.001 0.023
Significance was defined as P-value ,0.05, by Permutational Multivariate Analysis of Variance (PERMANOVA).
1. Sham - treated with broth.
2. Hh - H. hepaticus-infected.
3. WT- C57BL/6 mice.
4. FXR KO - Farnesoid X receptor knockout mice.
doi:10.1371/journal.pone.0106764.t001
Helicobacter hepaticus in FXR KO Mice
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the microbiota’s beta diversity. However, ANOVA analysis of the
relative abundance of bacteria at multiple taxonomical levels
showed no significant differences caused by H. hepaticus infection
(P,0.05 & FDR ,10%). In contrast, H. hepaticus-infected FXR
KO mice had significantly different alpha diversities, indicating
that the introduction of H. hepaticus, despite being a minority
species, greatly influenced the evenness and richness of the
microbiota. Significant differences in the relative abundance of the
genera Odoribacter, Helicobacter and an unknown genus from the
order YS2 within the phylum Cyanobacteria were also noted
(Table 3, P,0.05 and FDR ,10%). These results indicate that
while H. hepaticus is not the predominant species in the cecal
microbiota, its presence disrupts the microbial composition.
Discussion
Prior reports identified a 38 – 100% ‘‘spontaneous’’ hepatic
neoplasia incidence in FXR KO mice with preneoplastic foci
(FCA) and hepatitis-associated pro-inflammatory gene expression
[16,17]. FCA can occur spontaneously, and are also common
preneoplastic lesions found in rodent livers induced by long- and
short-term exposure to chemicals or other carcinogens. They
represent localized proliferations of hepatocytes that differ
phenotypically from adjacent liver parenchyma. Typically, they
comprise circular to ovoid foci of hepatocytes distinguishable from
adjacent liver predominantly by tinctorial variation, size of
hepatocytes, and absent to minimal compression of the surround-
ing parenchyma. FCA are subclassified based on their predom-
inant cell type: basophilic (normal-sized to enlarged hepatocytes
Table 2. Significant differences between all WT and FXR KO mice at multiple taxonomic levels.
PHYLUM P-value FDR1 rate
Mean Relative Abundance
in FXR KO mice
Mean Relative Abundance
in WT mice
p__Firmicutes 0.0009 0.7716% 46.32% 61.56%
p__Bacteroidetes 0.0267 12.0337% 35.70% 26.12%
CLASS P-value FDR rate Mean Relative Abundance
in FXR KO mice
Mean Relative Abundance
in WT mice
p__Firmicutes; c__Clostridia 0.0007 0.9611% 45.71% 61.38%
p__Proteobacteria; c__Deltaproteobacteria 0.0042 2.9458% 0.03% 0.23%
ORDER P-value FDR rate Mean Relative Abundance
in FXR KO mice
Mean Relative Abundance
in WT mice
p__Firmicutes; c__Clostridia; o__Clostridiales 0.0011 2.3302% 43.86% 58.83%
p__Proteobacteria; c__Deltaproteobacteria;
o__Desulfovibrionales
0.0042 4.4187% 0.03% 0.23%
FAMILY P-value FDR rate Mean Relative Abundance
in FXR KO mice
Mean Relative Abundance
in WT mice
p__Bacteroidetes; c__Bacteroidia;
o__Bacteroidales; f__
0.0000 0.0052% 0.00% 0.47%
p__Firmicutes; c__Clostridia; o__Clostridiales;
f__Peptococcaceae
0.0046 4.7452% 0.26% 0.04%
p__Bacteroidetes; c__Bacteroidia;
o__Bacteroidales; f__Prevotellaceae
0.0053 4.0827% 0.26% 0.04%
p__Proteobacteria; c__Deltaproteobacteria;
o__Desulfovibrionales; f__Desulfovibrionaceae
0.0042 6.5229% 0.03% 0.23%
GENUS P-value FDR rate Mean Relative Abundance
in FXR KO mice
Mean Relative Abundance
in WT mice
p__Bacteroidetes; c__Bacteroidia;
o__Bacteroidales;
f__; g__
0.0000 0.0065% 0.00% 0.47%
p__Firmicutes; c__Clostridia; o__Clostridiales;
f__Peptococcaceae; g__rc4-4
0.0046 8.9546% 0.26% 0.04%
p__Bacteroidetes; c__Bacteroidia; o__Bacteroidales;
f__Prevotellaceae; g__Prevotella
0.0053 6.8484% 0.26% 0.04%
p__Firmicutes; c__Clostridia; o__Clostridiales;
f__Ruminococcaceae; g__Oscillospira
0.0074 7.2332% 3.59% 6.05%
p__Proteobacteria; c__Deltaproteobacteria;
o__Desulfovibrionales; f__Desulfovibrionaceae;
g__Desulfovibrio
0.0093 7.2798% 0.02% 0.17%
p__Bacteroidetes; c__Bacteroidia; o__Bacteroidales;
f__Bacteroidaceae; g__
0.0150 9.7327% 0.00% 0.04%
p__Firmicutes; c__Clostridia; o__Clostridiales;
f__Lachnospiraceae; g__
0.0173 9.6167% 30.72% 41.48%
Taxa with significant differences (P,0.05 & FDR rate ,5% by ANOVA) are in bold. Italics denote taxa of interest with P,0.05 but FDR rate .5%.
1. FDR - False Discovery Rate.
doi:10.1371/journal.pone.0106764.t002
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with increased cytoplasmic basophilia); eosinophilic (enlarged
hepatocytes with hypereosinophilic staining intensity and cyto-
plasmic granularity); clear cell (normal-sized to enlarged hepato-
cytes with distinct cytoplasmic clear spaces); amphophilic (enlarged
hepatocytes with homogeneous, granular cytoplasm with ampho-
philic tinctorial appearance due to a combination of eosinophilia
and basophilia within foci); mixed cell (heterogeneous foci
comprising a mixture of any of the aforementioned cell types) [20].
Because enterohepatic Helicobacter spp. (EHS) cause hepatitis
and hepatic neoplasia in susceptible mouse strains, we hypothe-
sized that Helicobacter spp. infection was responsible for "spon-
taneous" liver disease in FXR KO mice. In this study, previously
Helicobacter-free H. hepaticus-infected FXR KO mice developed
significantly elevated hepatitis scores and increased FCA numbers
compared to Helicobacter-free WT controls. Helicobacter-free
FXR KO mice showed slightly elevated hepatitis scores and FCA
numbers that were not significantly different from sham-treated
controls. Helicobacter-infected controls only developed slightly
elevated hepatitis scores. Thus, synergy between H. hepaticus
infection and FXR deficiency were required to promote signifi-
cantly increase hepatic inflammation scores and preneoplastic
progression in this study.
Murine EHS originally gained appreciation for their confound-
ing effects on long-term carcinogenicity studies [3,5]. A recent
culture-based survey found 39% H. typhlonius prevalence in
North American mouse facilities, in addition to an overall 88%
worldwide EHS prevalence [1]. It is thus likely that Helicobacter
spp. substantially impacted data interpretation in numerous
published rodent studies. In humans, EHS DNA has been
identified in chronic cholecystitis and biliary tract neoplasia
patients [8,9], andH. hepaticus andH. bilis serum antibodies were
identified in various chronic hepatobiliary disease patients [21].
While the association between EHS infection and human disease
remains a subject of continued inquiry, murine Helicobacter spp.
infection remains a useful experimental model for the role of
intestinal bacteria in hepatic and gastrointestinal neoplasia.
When we obtained FXR KO founder mice, all mice were PCR-
positive for the rodent pathogen H. typhlonius, which causes
typhlocolitis in SCID and interleukin-10 KO mice [22,23],
prompting the need for embryo transfer rederivation. While
Figure 5. Microbiome composition by phylum. Individual bars represent individual mice from four groups (WT sham, WT H. hepaticus, FXR KO
sham and FXR KO H. hepaticus). There is a significant decrease (P,0.05, FDR ,5%, ANOVA) in the phylum Firmicutes in all FXR KO mice compared to
all WT mice (46.3% in FXR KO compared to 61.5% in WT).
doi:10.1371/journal.pone.0106764.g005
Table 3. ANOVA analysis of Differences in Relative Abundance at the genus level between sham and H. hepaticus infected FXR KO
mice.
OTU P-value FDR rate
FXR KO sham Mean
Relative Abundance
FXR KO Hh Mean Relative
Abundance
k__Bacteria; p__Bacteroidetes; c__Bacteroidia; o__Bacteroidales;
f__[Odoribacteraceae]; g__Odoribacter
0.0002 0.863% 0.00191 0.0089
k__Bacteria; p__Cyanobacteria; c__4C0d-2; o__YS2; f__; g__ 0.0047 8.670% 0.00503 0.001286
k__Bacteria; p__Proteobacteria; c__Epsilonproteobacteria;
o__Campylobacterales; f__Helicobacteraceae; g__Helicobacter
0.0071 8.706% 0 0.003382
Significance was defined as P,0.05 & FDR rate ,10% by ANOVA due to the reduced number of animals in this subset.
doi:10.1371/journal.pone.0106764.t003
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hepatic neoplasia has not been previously reported with H.
typhlonius-infected mice, 12–15-month-long infection with H.
typhlonius may have contributed to tumor formation in previous
studies [16,17]. The causal relationship between EHS infection
and neoplasia is further reinforced by numerous reports associat-
ing these pathogens with hepatitis and hepatocellular carcinoma
[3,10–13]. Remarkably, neoplastic progression in FXR mice was
noted on the C57BL/6 genetic background, which is typically
resistant to H. hepaticus-associated neoplasia [3,12]. This suggests
that strong FXR genotype-associated effects promoted neoplastic
progression in this and prior studies. Because FXR deficiency has
been shown to promote intestinal bacterial overgrowth [24], we
hypothesized that intestinal bacterial dysbiosis and H. hepaticus
infection acted synergistically during neoplastic progression.
In our analysis of the cecal microbiome, the taxa observed were
consistent with those reported for IL-10 KO mice at MIT and the
Hannover Medical School [25]. FXR deficiency promoted
significant shifts in bacterial populations, and was a more potent
modulator of bacterial diversity and composition than H.
hepaticus. In FXR KO mice, we observed significant increases
in the family Prevotellaceae. We also noted an increase in family
F16 in phylum TM7 in our analysis of relative abundance in H.
hepaticus-infected mice. Expanded representation of both family
Prevotellaceae and the phylum TM7 has been reported in colitic
mice [26]. In contrast, we also observed a 6-fold reduction in the
genus Desulfovibrio in FXR KO mice compared to WT mice.
These species have been associated with cases of ulcerative colitis
[27]. However, we also observed increases in the genus
Odoribacter due to H. hepaticus infection in FXR KO mice,
which has been associated with the microbiota of humans without
irritable bowel syndrome (IBS) [28].
FXR KO mice had significant decreases in bacteria from the
order Clostridiales, mostly from the family Lachnospiraceae. We
have previously reported the abundance of Lachnospiraceae in
MIT mouse colonies, including Clostridium species in cluster
XIVb, known for the induction of colonic regulatory T cells
[25,29]. At the same time, FXR deficiency also increased the
abundance of clostridia from the families Peptococcaceae and
Ruminococcaceae. The shifts in clostridial species are of special
note due to the observed increase in expression of VDR. This
result is suggestive of elevated hepatic bile acids, as lithocholic acid
(LCA) and its derivatives are VDR ligands and agonists [30–32].
An increase in LCA, a putative colon carcinogen [32–34], could
explain in part the role of H. hepaticus-induced hepatic lesions in
FXR KO mice. While all FXR KO mice experienced a large
decrease in clostridial species from the family Lachnospiraceae, a
concurrent infection with H. hepaticus might allow 7a-dehydrox-
ylating, anaerobic bacteria, such as Clostridium scindens VPI
12708, C. hiranonis DSM 13275, and C. hylemonae DSM 15053
[35–38], to increase in abundance, and promote LCA synthesis
through metabolism of the primary bile acid chenodeoxycholic
acid (CDCA) [13]. Although we did not detect significant changes
in these species, our results showed dynamic changes in Clostridia,
which require future characterization.
The murine homologues of human cytochrome P450 2B6 and
3A4, cytochromes P450 2B10 and 3A11, also have an important
function in phase I endobiotic and xenobiotic detoxification,
particularly in bile acid hydroxylation [39,40]. Both H. hepaticus
infection and FXR deficiency were required to induce a significant
increase in in Cyp2b10 relative to uninfected WT mice in this
study. The significant association between elevated Cyp2b10
expression and FCA formation in H. hepaticus-infected FXR KO
mice suggests that these preneoplastic changes resulted from
synergy between microbial infection and altered bile acid
detoxification. Our previous study in CAR KO mice hypothesized
that deregulation of Cyp2b10 also played a role in H. hepaticus-
mediated liver tumor development [13]. In the current study,
FXR deficiency alone increased Cyp3a11 expression, but H.
hepaticus infection was necessary to induce increased Cyp2b10
expression. The increased expression of these two genes suggests
an increased hepatic detoxification burden due to FXR deficiency
and H. hepaticus infection. These findings reinforce FXR’s role in
modulating inflammatory processes and promoting hepatic
functional capacity [41]. Importantly, FXR deficiency has been
identified in human hepatocellular carcinomas [42,43].
While not a dominant species in the cecal microbiota, H.
hepaticus promoted increased liver pathology, either through
direct effects or indirectly through changes in the microbial
composition. Using T-RFLP and 16S rRNA sequencing, two
previous studies showed that H. hepaticus becomes a dominant
member of the microbiota and reduced microbial diversity within
the mouse intestinal tract of WT and IL-10 KO mice [44,45]. In
this study, H. hepaticus infection did not significantly affect the
alpha diversity in WT mice after 1 year of infection, and had a low
relative abundance. Interestingly, however, in FXR KO mice, H.
hepaticus increased alpha diversity. Similarly, a previous study
conducted at MIT and the Hannover Medical School, did not
show H. hepaticus becoming a dominant member of the
microbiota of IL-10 C57BL KO mice [25]. Further studies are
necessary to determine how the duration of H. hepaticus infection
and baseline microbiome altered the outcome of H. hepaticus
infection. Our recent report demonstrated that inter-institutional
variation in microbiota is an important factor to consider in H.
hepaticus studies [25].
Loss of metabolic detoxification is a potential mechanism
contributing to the observed liver pathology. Our study, evaluating
the effect of chronic H. hepaticus infection and inflammation in
FXR KO mice, highlights how bacteria in the GI tract can impact
liver tumor promotion. Our findings illustrate the interplay
between nuclear receptors, gastrointestinal microbiome, and bile
acid metabolism that could be targeted as intervention strategy to
prevent liver cancer progression. Given that H. hepaticus
cytolethal distending toxin is known to promote hepatic dysplasia
in mice [46], further studies using germ-free, FXR KO mice are
needed to characterize if H. hepaticus alone is capable of
promoting liver dysplasia, or if its effects also require dysbiosis in
the intestinal microbiome.
Materials and Methods
Ethics Statement
This study was performed in strict accordance with the
recommendations in the Institute of Laboratory Animal Resourc-
es’ Guide for the Care and Use of Laboratory Animals. All mice
were fed a commercial rodent diet (Prolab RMH 3000; LabDiet)
ad libitum and housed in Association for Assessment and
Accreditation of Laboratory Animal Care International–approved
facilities. The protocol was approved by the Committee on Animal
Care of the Massachusetts Institute of Technology (Protocol
number: 0711-076-14). All mice were euthanized by CO2
inhalation.
Mice
Male and female FXR knock-out (KO) mice [B6;129X1(FVB)-
Nr1h4tm1Gonz] were obtained from the Laboratory of Metabolism
at the National Institutes of Health, Bethesda, MD, directed by
Dr. Frank J. Gonzalez. Upon receipt, they were embryo transfer
Helicobacter hepaticus in FXR KO Mice
PLOS ONE | www.plosone.org 9 September 2014 | Volume 9 | Issue 9 | e106764
rederived into a Helicobacter-free mouse colony. Helicobacter-free
FXR wild-type (WT) C57BL/6 mice were used as controls.
H. hepaticus infection
H. hepaticus strain 3B1 was obtained from a freezer stock and
cultured on trypticase soy agar plates with 5% sheep blood (Remel
Laboratories, Lenexa, KS) under microaerobic conditions (80%
N2, 10% CO2, 10% H2) at 37uC as previously described [13].
Groups (n = 16218) of both Helicobacter-free mouse strains were
inoculated with either sterile Brucella broth or approximately 109
H. hepaticus/mL by oral gavage 3 times over 5 days. Prior to and
1 month following infection, fecal pellets were collected from all
mice and DNA extracted using the QIAamp DNA Stool Mini Kit
(Qiagen, Valencia, CA). Helicobacter colonization status was
confirmed by PCR using the Expand High Fidelity PCR System
(Roche Applied Science, Indianapolis, IN) and previously
described Helicobacter genus-specific and H. hepaticus-specific
primers [8].
Histopathology and Immunohistochemistry
One year following infection, mice were euthanized by CO2
inhalation. Tissue samples were fixed in 10% formalin, paraffin
embedded, processed into 4 mm sections, and stained with
hematoxylin and eosin. Slides containing a section from all liver
lobes (left, right, median, and caudate lobes) were collected. The
entire small intestine, ileocecocolic junction, distal colon, gall
bladder, and mesenteric lymph node were evaluated by a board-
certified veterinary pathologist (N.M.A.P.) who was blinded to
sample identity. Hepatitis index was determined using previously
described methods [47]. The severity of lesions in the liver was
scored, according to previously defined criteria, using an
ascending scale from 0 to 4, based on the degree of lesion
severity: 0 (absent), 1 (mild), 2 (moderate), 3 (marked), and 4
(severe). Sections of liver were scored for lobular, portal and
interface hepatitis, and a hepatitis index was calculated by
combining the three scores plus the number of lobes (out of a
total of 4) that contained 5 or more inflammatory foci. Hepatitis
was defined by a hepatitis index equal to or greater than 4. Liver
sections were also scored for preneoplastic FCA.
To qualitatively assess the type of inflammatory cells, immuno-
histochemistry was performed on unstained serial sections of livers
of 3 infected animals from both the WT and FXR KO mice using
standard protocols as described previously [12,13]. The slides were
incubated at room temperature with one of the following
commercially available primary antibodies in optimal dilutions
to identify the different cell populations, namely anti-CD45/B220
(B cell marker), anti-CD3 (T cell marker), F4/80 (macrophages)
and myeloperoxidase (MPO) (predominantly neutrophils). Follow-
ing necessary blocking and washing steps, the slides were
incubated with appropriate species specific polymer based and
HRP (horse radish peroxidase) tagged secondary antibodies
(BioCare, USA) and followed by color development using a
chromogenic DAB (3,3’-diaminobenzidine) substrate for visuali-
zation under a light microscope.
H. hepaticus quantification
DNA was extracted from frozen cecum, liver, and ileum
samples using the High Pure PCR Template Preparation Kit
(Roche Applied Science, Indianapolis, IN). A previously described
hybridization probe-based qPCR assay was used to determine H.
hepaticus colonization levels per microgram of sample DNA [48].
Bile acids
Serum bile acids testing was performed by the Baylor College of
Medicine Diabetes and Endocrinology Research Center’s (DERC)
Mouse Metabolism Core (NIH P30 DK079638). Serum samples
with concentrations too low for detection were assigned the assay
working range’s minimum value (5 mmol/L) for data analysis.
Gene expression analysis
RNA was extracted from flash-frozen liver samples using
TRIzol reagent (Life Technologies, Carlsbad, CA). First-strand
cDNA synthesis was then achieved using the SuperScript III First-
Strand Synthesis System (Life Technologies, Carlsbad, CA).
Resulting cDNA was then utilized to determine relative gene
expression using commercially available hybridization probe-
based qPCR assays (Life Technologies, Carlsbad, CA). Relative
expression levels were determined using the DDct method, where
measured ct values were normalized to GAPDH [49]. The
Grubbs-Smirnov test was used to exclude a single outlier from the
WT sham group.
16S rRNA sequencing and analysis
DNA extracted from cecal samples collected 1 year after sham
treatment (WT, n= 7; FXR KO, n=7) or infection with Hh (WT,
n=7; FXR KO, n= 12) (High Pure PCR Template Preparation
Kit, Roche Applied Science) was amplified using universal primers
of F515 (GTGCCAGCMGCCGCGGTAA) and R806 (GGAC-
TACHVGGGTWTCTAAT) to target the V4 regions of 16S
rRNA of bacteria [50], and individual samples were barcoded and
pooled to construct the sequencing library, followed by sequencing
with an Illumina MiSeq instrument to generate pair-ended
1506150 reads. Overlapping pair-end reads were aligned using
SHE-RA [51] with subsequent analysis and normalization
performed using QIIME 1.7.0 [52]. Cecal communities were
compared by using UniFrac, a phylogeny-based distance metric
that measures the degree to which any two microbiota share
branch length on a Bacterial tree of life. As a first step, sequence
data and metadata were combined to de-multiplex the barcoded
reads and quality filtering was done using the default parameters
in QIIME. Sequences were grouped into OTUs (Operational
Taxonomic Units) at 97% sequence similarity using uclust.
Taxonomy was assigned using Ribosomal Database Project
(RDP) classifier against GreenGenes database, and sequences
were aligned and phylogenetic tree was built from reference
sequences using FastTree. An OTU table showing counts of each
OTU in each sample was produced. To control for differences in
sequencing depth, OTU tables were rarified at a single sequencing
depth [53,54]. Alpha diversity was determined using Shannon and
Chao1 index and is represented as rarefaction curves. Beta
diversity was determined using unweighted and weighted UniFrac
[55] and the results presented as principal coordinate axis (PCoA)
plots. The OTU’s were summarized at different taxonomic levels
from phylum to genus and differences in the relative abundance at
different taxonomic levels were determined using ANOVA with a
false discovery rate of 5 or 10%.
Statistical analysis
All statistical analyses (a=0.05) were performed using Graph-
Pad Prism 5 (GraphPad Software, La Jolla, CA). If data were
normally distributed based on the Kolmogorov-Smirnov test,
groups were compared using 1-way ANOVA and p-values
generated using the Student-Neuman-Keuls multiple comparison
procedure. If data sets were not normally distributed, due to either
skew or non-continuous nature (histopathology metrics), the
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Kruskal-Wallis test and Dunn’s multiple comparison procedure
were used. The Mann-Whitney U test was used to compare FCA-
positive and negative infected FXR KO mice.
Supporting Information
Figure S1 Immunohistochemistry assessing liver infil-
tration of A) B cells (anti-CD45/B220), B) T cells (anti-
CD3), and C) macrophages (F4/80) in a representative
H. hepaticus-infected FXR KO mice. The distinct portal
inflammatory aggregates are mostly B cells with significant
presence of T cells and lack of staining for macrophages. Bar
= 75 mm.
(TIF)
Figure S2 Unweighted UniFrac-based PCoA plots of
subsets of cecal microbiota. Both A) WT and B) FXR KO
mice showed clustering due to H. hepaticus (Both P=0.001,
PERMANOVA). Both C) Sham and D) H. hepaticus-infected
mice showed clustering due to FXR status (Both P=0.001,
PERMANOVA).
(TIF)
Figure S3 Weighted UniFrac-based PCoA plots of sub-
sets of cecal microbiota. H. hepaticus infection did not affect
clustering of microbiota in A) WT and B) FXR KO mice
(P=0.263 and 0.218, PERMANOVA). C) Sham treated mice did
not reveal differences in clustering (P=0.053, PERMANOVA),
while D) H. hepaticus-infected mice showed clustering due to FXR
status (P=0.023, PERMANOVA).
(TIF)
Table S1 Percent Composition of each group by phy-
lum.
(XLSX)
Table S2 Top 25 genera ranked by % of total micro-
biome in each group.
(XLSX)
Table S3 Top 150 OTUs ranked by % of total micro-
biome in each group.
(XLSX)
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